Therapy Areas: Respiratory
17 November 2026 - Chinese pharmaceutical company Akeso Inc (HKEX:9926) announced on Monday that China's National Medical Products Administration (NMPA) has accepted its supplemental New Drug App...
11 November 2026 - Precision oncology company Guardant Health Inc (Nasdaq: GH) announced on Wednesday that it has expanded its Guardant360 Liquid cancer testing capabilities with new epigenomic applic...
6 November 2026 - Chinese pharmaceutical company Akeso Inc (HKEX:9926) announced on Thursday that results from a Phase II clinical study evaluating its first-in-class PD-1/VEGF bispecific antibody ivo...
4 November 2026 - Swedish precision oncology company CHOSA Oncology AB (Spotlight Stock Market: CHOSA) said on Wednesday it has signed an agreement with a CLIA-certified laboratory to develop and vali...
4 November 2026 - Biotechnology company United Therapeutics Corporation (Nasdaq:UTHR) announced on Wednesday that it has entered into an amended agreement with Arena Pharmaceuticals, a subsidiary of P...
3 November 2026 - US pharmaceutical company Merck & Co Inc (NYSE:MRK), known as MSD outside the US and Canada, announced on Tuesday that it has initiated ENHANCE-3, a Phase 3 clinical trial evalua...